These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 30252097)

  • 41. Characterization of the role of N-glycosylation sites in the respiratory syncytial virus fusion protein in virus replication, syncytium formation and antigenicity.
    Leemans A; Boeren M; Van der Gucht W; Martinet W; Caljon G; Maes L; Cos P; Delputte P
    Virus Res; 2019 Jun; 266():58-68. PubMed ID: 31004621
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Packaging and Prefusion Stabilization Separately and Additively Increase the Quantity and Quality of Respiratory Syncytial Virus (RSV)-Neutralizing Antibodies Induced by an RSV Fusion Protein Expressed by a Parainfluenza Virus Vector.
    Liang B; Ngwuta JO; Herbert R; Swerczek J; Dorward DW; Amaro-Carambot E; Mackow N; Kabatova B; Lingemann M; Surman S; Yang L; Chen M; Moin SM; Kumar A; McLellan JS; Kwong PD; Graham BS; Schaap-Nutt A; Collins PL; Munir S
    J Virol; 2016 Nov; 90(21):10022-10038. PubMed ID: 27581977
    [TBL] [Abstract][Full Text] [Related]  

  • 43. BRD4 Couples NF-κB/RelA with Airway Inflammation and the IRF-RIG-I Amplification Loop in Respiratory Syncytial Virus Infection.
    Tian B; Yang J; Zhao Y; Ivanciuc T; Sun H; Garofalo RP; Brasier AR
    J Virol; 2017 Mar; 91(6):. PubMed ID: 28077651
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Actin- and clathrin-dependent mechanisms regulate interferon gamma release after stimulation of human immune cells with respiratory syncytial virus.
    Jans J; elMoussaoui H; de Groot R; de Jonge MI; Ferwerda G
    Virol J; 2016 Mar; 13():52. PubMed ID: 27004689
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effects of Alterations to the CX3C Motif and Secreted Form of Human Respiratory Syncytial Virus (RSV) G Protein on Immune Responses to a Parainfluenza Virus Vector Expressing the RSV G Protein.
    Liang B; Kabatova B; Kabat J; Dorward DW; Liu X; Surman S; Liu X; Moseman AP; Buchholz UJ; Collins PL; Munir S
    J Virol; 2019 Apr; 93(7):. PubMed ID: 30651356
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The Interferon Type I/III Response to Respiratory Syncytial Virus Infection in Airway Epithelial Cells Can Be Attenuated or Amplified by Antiviral Treatment.
    McCutcheon KM; Jordan R; Mawhorter ME; Noton SL; Powers JG; Fearns R; Cihlar T; Perron M
    J Virol; 2016 Feb; 90(4):1705-17. PubMed ID: 26608311
    [TBL] [Abstract][Full Text] [Related]  

  • 47. CD38 modulates respiratory syncytial virus-driven proinflammatory processes in human monocyte-derived dendritic cells.
    Schiavoni I; Scagnolari C; Horenstein AL; Leone P; Pierangeli A; Malavasi F; Ausiello CM; Fedele G
    Immunology; 2018 May; 154(1):122-131. PubMed ID: 29178427
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Difference in respiratory syncytial virus-specific Fc-mediated antibody effector functions between children and adults.
    Lakerveld AJ; Gelderloos AT; Schepp RM; de Haan CAM; van Binnendijk RS; Rots NY; van Beek J; van Els CACM; van Kasteren PB
    Clin Exp Immunol; 2023 Dec; 214(1):79-93. PubMed ID: 37605554
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Consequences of immature and senescent immune responses for infection with respiratory syncytial virus.
    Malloy AM; Falsey AR; Ruckwardt TJ
    Curr Top Microbiol Immunol; 2013; 372():211-31. PubMed ID: 24362692
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Development and Standardization of a High-Throughput Multiplex Immunoassay for the Simultaneous Quantification of Specific Antibodies to Five Respiratory Syncytial Virus Proteins.
    Schepp RM; de Haan CAM; Wilkins D; Layman H; Graham BS; Esser MT; Berbers GAM
    mSphere; 2019 Apr; 4(2):. PubMed ID: 31019002
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Differential Responses by Human Respiratory Epithelial Cell Lines to Respiratory Syncytial Virus Reflect Distinct Patterns of Infection Control.
    Hillyer P; Shepard R; Uehling M; Krenz M; Sheikh F; Thayer KR; Huang L; Yan L; Panda D; Luongo C; Buchholz UJ; Collins PL; Donnelly RP; Rabin RL
    J Virol; 2018 Aug; 92(15):. PubMed ID: 29769339
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Live Respiratory Syncytial Virus (RSV) Vaccine Candidate Containing Stabilized Temperature-Sensitivity Mutations Is Highly Attenuated in RSV-Seronegative Infants and Children.
    Buchholz UJ; Cunningham CK; Muresan P; Gnanashanmugam D; Sato P; Siberry GK; Rexroad V; Valentine M; Perlowski C; Schappell E; Thumar B; Luongo C; Barr E; Aziz M; Yogev R; Spector SA; Collins PL; McFarland EJ; Karron RA;
    J Infect Dis; 2018 Apr; 217(9):1338-1346. PubMed ID: 29509929
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Human Respiratory Syncytial Virus: An Introduction.
    Jorquera PA; Anderson L; Tripp RA
    Methods Mol Biol; 2016; 1442():1-12. PubMed ID: 27464683
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Virus-Specific Antibody, Viral Load, and Disease Severity in Respiratory Syncytial Virus Infection.
    Walsh EE; Wang L; Falsey AR; Qiu X; Corbett A; Holden-Wiltse J; Mariani TJ; Topham DJ; Caserta MT
    J Infect Dis; 2018 Jun; 218(2):208-217. PubMed ID: 29546402
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Interaction of respiratory syncytial virus with human cord blood mononuclear cells.
    Kositanont U; Vuddhakul V; Kositanont C; Thong YH
    Asian Pac J Allergy Immunol; 1992 Dec; 10(2):135-9. PubMed ID: 1305815
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The role of IFN in respiratory syncytial virus pathogenesis.
    Durbin JE; Johnson TR; Durbin RK; Mertz SE; Morotti RA; Peebles RS; Graham BS
    J Immunol; 2002 Mar; 168(6):2944-52. PubMed ID: 11884466
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Coptidis Rhizoma extract inhibits replication of respiratory syncytial virus in vitro and in vivo by inducing antiviral state.
    Lee BH; Chathuranga K; Uddin MB; Weeratunga P; Kim MS; Cho WK; Kim HI; Ma JY; Lee JS
    J Microbiol; 2017 Jun; 55(6):488-498. PubMed ID: 28551874
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cellular Immune Correlates Preventing Disease Against Respiratory Syncytial Virus by Vaccination with Virus-Like Nanoparticles Carrying Fusion Proteins.
    Lee YT; Ko EJ; Kim KH; Hwang HS; Lee Y; Kwon YM; Kim MC; Lee YN; Jung YJ; Kang SM
    J Biomed Nanotechnol; 2017 Jan; 13(1):84-98. PubMed ID: 29302248
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Characteristics of RSV-Specific Maternal Antibodies in Plasma of Hospitalized, Acute RSV Patients under Three Months of Age.
    Jans J; Wicht O; Widjaja I; Ahout IM; de Groot R; Guichelaar T; Luytjes W; de Jonge MI; de Haan CA; Ferwerda G
    PLoS One; 2017; 12(1):e0170877. PubMed ID: 28135305
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Functional capacity of natural killer cells in HTLV-1 associated myelopathy/tropical spastic paraparesis (HAM/TSP) patients.
    Queiroz GAN; Mascarenhas REM; Vieillard V; Andrade RL; Galvão-Castro B; Grassi MFR
    BMC Infect Dis; 2019 May; 19(1):433. PubMed ID: 31101076
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.